申请人:Dillon Michael Patrick
公开号:US08476457B2
公开(公告)日:2013-07-02
Compounds of the formula I:
or a pharmaceutically acceptable salt thereof, wherein, X, Y, Z, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of using the compounds for treating diseases associated with P2X3 and/or a P2X2/3 receptor antagonists and methods of making the compounds.
化合物I的公式为:或其药学上可接受的盐,其中,X、Y、Z、R1、R2、R3、R4和R5的定义如本文所述。本文还披露了使用这些化合物治疗与P2X3和/或P2X2/3受体拮抗剂相关的疾病的方法以及制备这些化合物的方法。